Vivimed Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs has informed the stock exchanges that its trading window will remain closed from October 1, 2025 until 48 hours after the declaration of its financial results for the quarter and half year ended September 30, 2025. This closure is in line with the company's Code of Conduct for Prohibition of Insider Trading, as mandated under SEBI regulations. The board meeting date to announce the Q2 and H1 FY26 results has not yet been disclosed and will be communicated separately.
This is a routine compliance filing and does not directly impact shareholders. The window closure simply restricts insiders, directors, and designated employees from trading in the company's shares during the results period to prevent insider trading.